Suppr超能文献

呈现一种免疫优势的即刻早期 CD8+ T 细胞表位,可抵抗人类巨细胞病毒的免疫逃逸。

Presentation of an immunodominant immediate-early CD8+ T cell epitope resists human cytomegalovirus immunoevasion.

机构信息

Clinical Cooperation Group Immunooncology, Department of Medicine III, Klinikum der Universität München, Helmholtz Zentrum München, Munich, Germany.

出版信息

PLoS Pathog. 2013;9(5):e1003383. doi: 10.1371/journal.ppat.1003383. Epub 2013 May 23.

Abstract

Control of human cytomegalovirus (HCMV) depends on CD8+ T cell responses that are shaped by an individual's repertoire of MHC molecules. MHC class I presentation is modulated by a set of HCMV-encoded proteins. Here we show that HCMV immunoevasins differentially impair T cell recognition of epitopes from the same viral antigen, immediate-early 1 (IE-1), that are presented by different MHC class I allotypes. In the presence of immunoevasins, HLA-A- and HLA-B-restricted T cell clones were ineffective, but HLA-C0702-restricted T cell clones recognized and killed infected cells. Resistance of HLA-C0702 to viral immunoevasins US2 and US11 was mediated by the alpha3 domain and C-terminal region of the HLA heavy chain. In healthy donors, HLA-C*0702-restricted T cells dominated the T cell response to IE-1. The same HLA-C allotype specifically protected infected cells from attack by NK cells that expressed a corresponding HLA-C-specific KIR. Thus, allotype-specific viral immunoevasion allows HCMV to escape control by NK cells and HLA-A- and HLA-B-restricted T cells, while the virus becomes selectively vulnerable to an immunodominant population of HLA-C-restricted T cells. Our work identifies a T cell population that may be of particular efficiency in HCMV-specific immunotherapy.

摘要

人类巨细胞病毒 (HCMV) 的控制依赖于 CD8+ T 细胞反应,这些反应受个体 MHC 分子谱的影响。MHC Ⅰ类呈递受一组 HCMV 编码蛋白的调节。在这里,我们表明 HCMV 免疫逃逸蛋白可不同程度地损害针对同一病毒抗原(早期立即 1 [IE-1])表位的 T 细胞识别,这些表位由不同的 MHC Ⅰ类同种异型呈递。在免疫逃逸蛋白存在的情况下,HLA-A 和 HLA-B 限制性 T 细胞克隆无效,但 HLA-C0702 限制性 T 细胞克隆识别并杀死感染细胞。HLA-C0702 对病毒免疫逃逸蛋白 US2 和 US11 的抗性由 HLA 重链的α3 结构域和 C 末端区域介导。在健康供体中,HLA-C*0702 限制性 T 细胞主导了对 IE-1 的 T 细胞反应。相同的 HLA-C 同种异型特异性保护感染细胞免受表达相应 HLA-C 特异性 KIR 的 NK 细胞的攻击。因此,同种异型特异性病毒免疫逃逸使 HCMV 能够逃避 NK 细胞和 HLA-A 和 HLA-B 限制性 T 细胞的控制,而病毒变得对 HLA-C 限制性 T 细胞的免疫优势群体具有选择性易感性。我们的工作确定了一种 T 细胞群体,它在 HCMV 特异性免疫治疗中可能具有特别高的效率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e62/3662661/46e2c849a51c/ppat.1003383.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验